Richard A. Miller MD - 18 May 2026 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Reporting relationship: President and CEO, Director
Issuer ticker: CRVS
Reported as of: 18 May 2026
Net transaction value: +$83,453
SEC form: 4
Accepted by SEC: 20 May 2026, 16:12:25 UTC
Prior SEC filing: 08 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller

Key filing fact

Richard A. Miller MD filed Form 4 for Corvus Pharmaceuticals, Inc. (CRVS) on 20 May 2026.

Key facts

This page summarizes Richard A. Miller MD's Form 4 filing for Corvus Pharmaceuticals, Inc. (CRVS).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 20 May 2026, 16:12.

Change

Previous filing in this sequence was filed on 08 Dec 2025.
Current net transaction value: +$83,453.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001031847 Primary reporting owner

MILLER RICHARD A MD

Relationship: President and CEO, Director
Address: C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO
Signature: /s/ Leiv Lea, as Attorney-in-Fact for Richard A. Miller
Signature date: 20 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CRVS transaction

Common Stock

Purchase

Transaction value: $60,250
Shares: +5,000
Change %: +0.42%
Price: $12.05
Shares after: 1,193,103
Date: 18 May 2026
Ownership: By Trust
Footnotes: F1

CRVS transaction

Common Stock

Purchase

Transaction value: $23,203
Shares: +1,932
Change %: +0.16%
Price: $12.01
Shares after: 1,195,035
Date: 18 May 2026
Ownership: By Trust
Footnotes: F1

CRVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,136,707
Date: 18 May 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are held by Richard A. Miller and Sandra J. Horning, Trustees of the Miller-Horning Family Trust u/a/d January 25, 1985 (the "Miller-Horning Trust"). Dr. Miller has shared voting, investment and dispositive power over the shares held by the Miller Horning Trust.